Safe Orthopaedics announced the European launch of a bone substitute for its Walnut cervical cage. The company also received FDA 510(k) clearance for the SteriSpine™CC range, which includes the Walnut cage.
Although it is not commercialized in the U.S., this technology will gain more rapid approval in certain countries such as Latin America and the Asia-Pacific region.
In 2016 Safe Orthopaedics confirmed initial successful surgeries using SteriSpineCC devices, as well as expansion into Latin America under distribution agreements covering Chile and Mexico.
Safe Orthopaedics announced the European launch of a bone substitute for its Walnut cervical cage. The company also received FDA 510(k) clearance for the SteriSpine™CC range, which includes the Walnut cage.
Although it is not commercialized in the U.S., this technology will gain more rapid approval in certain countries such as Latin America...
Safe Orthopaedics announced the European launch of a bone substitute for its Walnut cervical cage. The company also received FDA 510(k) clearance for the SteriSpine™CC range, which includes the Walnut cage.
Although it is not commercialized in the U.S., this technology will gain more rapid approval in certain countries such as Latin America and the Asia-Pacific region.
In 2016 Safe Orthopaedics confirmed initial successful surgeries using SteriSpineCC devices, as well as expansion into Latin America under distribution agreements covering Chile and Mexico.
Copy to clipboard 
